Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery

Journal of the American College of Cardiology

Volumn 69, Issue 14, 2017, Pages 1861-1870

  Banerjee, Subhash ^a,b   Angiolillo, Dominick J ^c   Boden, William E ^d   Murphy, Joseph G ^e   Khalili, Houman ^a,b   Hasan, Ahmed A ^f   Harrington, Robert A ^g   Rao, Sunil V ^h,i  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d Division of SCI Research   (United States)

^e MAYO CLINIC   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ DURHAM VA MEDICAL CENTER   (United States)

Author keywords

aspirin; coronary balloon angioplasty; drug eluting stents; risk assessment; stents; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GLYCERYL TRINITRATE; PRASUGREL; TICAGRELOR; TROPONIN I; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ANGINA PECTORIS; CASE REPORT; CHOLECYSTECTOMY; CHOLELITHIASIS; COLON CARCINOMA; COLON OBSTRUCTION; COLONOSCOPY; CORONARY ANGIOGRAPHY; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING CORONARY STENT; DUAL ANTIPLATELET THERAPY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE REPLACEMENT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOW DRUG DOSE; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIOPERATIVE PERIOD; RECTUM HEMORRHAGE; REVIEW; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THORAX PAIN; THROMBECTOMY;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS;

EID: 85016930035     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.02.012     Document Type: Review

References (48)

1. 1 Oprea, A.D., Popescu, W.M., Perioperative management of antiplatelet therapy. Br J Anaesth 111:Suppl 1 (2013), i3–i17.
2. 2 Rao, S.V., Shaw, R.E., Brindis, R.G., et al. Patterns and outcomes of drug-eluting coronary stent use in clinical practice. Am Heart J 152 (2006), 321–326.
3. 3 Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation 131 (2015), e29–e322.
4. 4 Alshawabkeh, L.I., Prasad, A., Lenkovsky, F., et al. Outcomes of a preoperative “bridging” strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration. EuroIntervention 9 (2013), 204–211.
5. 5 van Diepen, S., Tricoci, P., Podder, M., et al. Efficacy and safety of vorapaxar in non-ST-segment elevation acute coronary syndrome patients undergoing noncardiac surgery. J Am Heart Assoc, 4, 2015, e002546.
6. 6 Amsterdam, E.A., Wenger, N.K., Brindis, R.G., et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64 (2014), e139–e228.
7. 7 Davierwala, P.M., Verevkin, A., Leontyev, S., et al. Does timing of coronary artery bypass surgery affect early and long-term outcomes in patients with non-ST-segment-elevation myocardial infarction?. Circulation 132 (2015), 731–740.
8. 8 Spertus, J.A., Kettelkamp, R., Vance, C., et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113 (2006), 2803–2809.
9. 9 Hawn, M.T., Graham, L.A., Richman, J.S., et al. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 310 (2013), 1462–1472.
10. 10 Palmerini, T., Sangiorgi, D., Valgimigli, M., et al. Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis. J Am Coll Cardiol 65 (2015), 1092–1102.
11. 11 Egholm, G., Kristensen, S.D., Thim, T., et al. Risk associated with surgery within 12 months after coronary drug-eluting stent implantation. J Am Coll Cardiol 68 (2016), 2622–2632.
12. 12 Levine, G.N., Bates, E.R., Bittl, J.A., et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 68 (2016), 1082–1115.
13. 13 Alfonso, F., Hernandez, R., Goicolea, J., et al. Coronary stenting for acute coronary dissection after coronary angioplasty: implications of residual dissection. J Am Coll Cardiol 24 (1994), 989–995.
14. 14 Rossini, R., Musumeci, G., Visconti, L.O., et al. Italian Society of Invasive Cardiology (SICI-GISE) Italian Association of Hospital Cardiologists (ANMCO) Italian Society for Cardiac Surgery (SICCH) Italian Society of Vascular and Endovascular Surgery (SICVE) Italian Association of Hospital Surgeons (ACOI) Italian Society of Surgery (SIC) Italian Society of Anaesthesia and Intensive Care Medicine (SIAARTI) Lombard Society of Surgery (SLC) Italian Society of Maxillofacial Surgery (SICMF) Italian Society of Reconstructive Plastic Surgery and Aesthetics (SICPRE) Italian Society of Thoracic Surgeons (SICT) Italian Society of Urology (SIU) Italian Society of Orthopaedics and Traumatology (SIOT) Italian Society of Periodontology (SIdP) Italian Federation of Scientific Societies of Digestive System Diseases Lombardia (FISMAD) Association of Obstetricians Gynaecologists Italian Hospital Lombardia (AOGOI), Society of Ophthalmology Lombardia (SOL). Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention 10 (2014), 38–46.
15. 15 Berger, P.B., Bellot, V., Bell, M.R., et al. An immediate invasive strategy for the treatment of acute myocardial infarction early after noncardiac surgery. Am J Cardiol 87 (2001), 1100–1102 A6, A9.
16. 16 Rossini, R., Angiolillo, D.J., Musumeci, G., et al. Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: results of the Surgery After Stenting Registry. Catheter Cardiovasc Interv 89 (2017), E13–E25.
17. 17 Brilakis, E.S., Banerjee, S., Kampaliotis, D., et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol Intv 8 (2015), 245–253.
18. 18 Suh, J., Park, D.W., Lee, J.Y., et al. The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation. J Am Coll Cardiol Intv 3 (2010), 383–389.
19. 19 Giustino, G., Chieffo, A., Palmerini, T., et al. Efficacy and safety of dual antiplatelet therapy after complex PCI. J Am Coll Cardiol 68 (2016), 1851–1864.
20. 20 Feres, F., Costa, R.A., Abizaid, A., et al., OPTIMIZE Trial Investigators. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA 310 (2013), 2510–2522.
21. 21 Kristensen, S.D., Knuuti, J., Saraste, A., et al. [2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management]. Kardiol Pol 72 (2014), 857–918.
22. 22 Fleisher, L.A., Fleichman, K.E., Auerbach, A.D., et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 64 (2014), e77–e137.
23. 23 Oscarsson, A., Gupta, A., Fredrikson, M., et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 104 (2010), 305–312.
24. 24 Kaluza, G.L., Joseph, J., Lee, J.R., et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35 (2000), 1288–1294.
25. 25 Devereaux, P.J., Mrkobrada, M., Sessler, D.I., et al., POISE-2 Investigators. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 370 (2014), 1494–1503.
26. 26 Jakubowski, J.A., Li, Y.G., Payne, C.D., et al. Absence of “rebound” platelet hyperreactivity following cessation of prasugrel. Thromb Haemost 106 (2011), 174–176.
27. 27 Zheng, H., Ma, H.P., Chen, L., et al. Prethrombotic state and cardiac events in patients with coronary heart disease during noncardiac surgery. Clin Appl Thromb Hemost 20 (2014), 84–90.
28. 28 Ford, I., Scott, N.W., Herd, V., et al. A randomized controlled trial of platelet activity before and after cessation of clopidogrel therapy in patients with stable cardiovascular disease. J Am Coll Cardiol 63 (2014), 233–239.
29. 29 Angiolillo, D.J., Fernando-Ortiz, A., Bernardo, E., et al. Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease. Diabetes 55 (2006), 780–784.
30. 30 Schouten, O., van Domburg, R.T., Bax, J.J., et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 49 (2007), 122–124.
31. 31 Mehran, R., Baber, U., Steg, P.G., et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 382 (2013), 1714–1722.
32. 32 Burger, W., Chemnitius, J.M., Kneissi, G.D., et al. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 257 (2005), 399–414.
33. 33 Thurston, A.V., Briant, S.L., Aspirin and post-prostatectomy haemorrhage. Br J Urol 71 (1993), 574–576.
34. 34 Palmer, J.D., Sparrow, O.C., Iannotti, F., Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 35 (1994), 1061–1064 discussion 1064–5.
35. 35 Bonaca, M.P., Braunwald, E., Sabatine, M.S., et al. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med 373 (2015), 1274–1275.
36. 36 Rollini, F., Franchi, F., Angiolillo, D.J., et al. Switching P2Y12 receptor inhibiting therapies. Interv Cardiol Clin 6 (2017), 67–89.
37. 37 Elewa, H., Ahmed, D., Barnes, G.D., et al. Triple oral antithrombotic therapy in atrial fibrillation and coronary artery stenting: searching for the best combination. Semin Thromb Hemost 42 (2016), 662–670.
38. 38 Angiolillo, D.J., Goodman, S.G., Bhatt, D.L., et al. Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a North American perspective-2016 update. Circ Cardiovasc Interv, 9, 2016, e004395.
39. 39 van Kuijk, J.P., Flu, W.J., Schouten, O., et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol 104 (2009), 1229–1234.
40. 40 Armstrong, E.J., Sab, S., Singh, G.D., et al. Predictors and outcomes of recurrent stent thrombosis: results from a multicenter registry. J Am Coll Cardiol Intv 7 (2014), 1105–1113.
41. 41 Capodanno, D., Musumeci, G., Lettieri, C., et al. Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery. Thromb Haemost 114 (2015), 423–431.
42. 42 Capodanno, D., Angiolillo, D.J., Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation 128 (2013), 2785–2798.
43. 43 Angiolillo, D.J., Firstenberg, M.S., Price, M.J., et al., BRIDGE Investigators. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 307 (2012), 265–274.
44. 44 Petricevic, M., Milicic, D., White, A., et al. Development of a concept for a personalized approach in the perioperative antiplatelet therapy administration/discontinuation management based on multiple electrode aggregometry in patients undergoing coronary artery surgery. J Thromb Thrombolysis 40 (2015), 383–391.
45. 45 Savonitto, S., D'Urbano, M., Caracciolo, M., et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of ‘bridging’ antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth 104 (2010), 285–291.
46. 46 Warshauer, J., Patel, V.G., Christopoulos, G., et al. Outcomes of preoperative bridging therapy for patients undergoing surgery after coronary stent implantation: a weighted meta-analysis of 280 patients from eight studies. Catheter Cardiovasc Interv 85 (2015), 25–31.
47. 47 Khair, T., Garcia, B., Banerjee, S., et al. Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: a survey of 374 interventional cardiologists. Cardiovasc Revasc Med 12 (2011), 99–104.
48. 48 Navarese, E.P., Andreotti, F., Schulze, V., et al. Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials. BMJ, 350, 2015, h1618.